Weight problems medication had been first authorized to deal with kind 2 diabetes, however there’s a rising motion to check them in kind 1 diabetes, too. Analysis introduced Monday at a big diabetes assembly confirmed some promise for this strategy.
Sufferers who took a GLP-1 drug fared higher than these in a management group at preserving their blood glucose ranges in a wholesome vary whereas additionally shedding extra weight than those that weren’t taking the drug.
The double-blinded, randomized management trial enrolled 72 adults with a BMI of 30 or increased who use automated insulin supply techniques to handle their kind 1 diabetes. Cut up into two teams, half acquired weekly 1-milligram injections of semaglutide — the popular GLP-1 drug and dose when the examine was designed 5 years in the past — and half acquired a placebo.
This text is unique to STAT+ subscribers
Unlock this text — plus in-depth evaluation, newsletters, premium occasions, and information alerts.
Have already got an account? Log in
To learn the remainder of this story subscribe to STAT+.
